| __timestamp | Celldex Therapeutics, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 15411924 |
| Thursday, January 1, 2015 | 100171000 | 22593274 |
| Friday, January 1, 2016 | 102726000 | 33173050 |
| Sunday, January 1, 2017 | 96171000 | 62224159 |
| Monday, January 1, 2018 | 66449000 | 95607434 |
| Tuesday, January 1, 2019 | 42672000 | 221269028 |
| Wednesday, January 1, 2020 | 42534000 | 400745069 |
| Friday, January 1, 2021 | 53311000 | 580520000 |
| Saturday, January 1, 2022 | 82258000 | 663366000 |
| Sunday, January 1, 2023 | 118011000 | 755113687 |
Data in motion
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, argenx SE and Celldex Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D). From 2014 to 2023, argenx SE has consistently outpaced Celldex in R&D spending, with a staggering 3900% increase, peaking at over $750 million in 2023. In contrast, Celldex's R&D expenses have seen a more modest growth, with a 13% increase over the same period, reaching approximately $118 million in 2023. This significant disparity highlights argenx SE's aggressive strategy to lead in innovation. As the biotech industry continues to evolve, these investments could be pivotal in determining which company will emerge as a leader in groundbreaking therapies.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or argenx SE: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: BeiGene, Ltd. vs Celldex Therapeutics, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Celldex Therapeutics, Inc.
R&D Insights: How Exelixis, Inc. and Celldex Therapeutics, Inc. Allocate Funds
Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Celldex Therapeutics, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.